In today's world, ATC code J02 is a topic that generates great interest and discussion. With the advancement of technology and globalization, ATC code J02 has acquired a relevance never seen before, impacting different aspects of society and daily life. From its influence on politics and the economy, to its effect on culture and education, ATC code J02 has become a central issue on the public agenda. In this article, we will explore the various perspectives and debates surrounding ATC code J02, analyzing its importance and implications in the contemporary world.
| ATC code J: Antiinfectives for systemic use |
|---|
|
| Human only |
| ATCvet only |
|
| Other ATC codes |
ATC code J02 Antimycotics for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup J02 is part of the anatomical group J Antiinfectives for systemic use.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QJ02.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.